Ginger (fresh or tea) reduces nausea
Recent analyses presented at the National Lipid Associations 2025 Scientific Sessions highlighted cardiovascular, renal, and metabolic gains from GLP1s that appear partly independent of the amount of weight loss
Eligibility and contraindications Each of these medications comes with eligibility criteria, but these drugs are generally indicated for: Adults who have obesity (BMI of 30 or above) Adults who have overweight (BMI of 27 or above) as well as a weight-related comorbid condition, such as high blood pressure, type 2 diabetes, and obstructive sleep apnea Some groups of people should not take these medications, including: People who are pregnant People with a personal or family history of medullary thyroid cancer People who have a known serious hypersensitivity to the ingredients in the medication Additionally, you should not use these medications in combination or with other weight loss medications
What GLP-1 Actually Is GLP-1 stands for Glucagon Like Peptide 1
Retatrutide is a next-generation triple agonist (GLP-1, GIP, and GCGR) widely examined in laboratory studies focused on energy balance, metabolic regulation, and multi-pathway peptide signalling
WeightWatchers may have just solved that
